SEARCH

SEARCH BY CITATION

References

  • 1
    Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112: 212037.
  • 2
    Chey WD, Olden K, Carter E, et al. Utility of the Rome I and Rome II criteria for IBS in US women. Am J Gastroenterol 2002; 97: 280311.
    Direct Link:
  • 3
    Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990; 99: 40915.
  • 4
    Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional GI disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 156980.
  • 5
    Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 114056.
  • 6
    Azpiroz F, Dapoigny M, Pace F, et al. Nongastrointestinal disorders in the irritable bowel syndrome. Digestion 2000; 62: 6672.
  • 7
    Talley NJ, Gabriel SE, Harmsen WS, et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995; 109: 173641.
  • 8
    Goodman C, Cronin K, Gemmen E, et al. In: The Burden of Gastrointestinal Diseases. Bethesda, MD: American Gastroenterological Association, 2001: 265.
  • 9
    Martin R, Barron JJ, Zacker C. Irritable bowel syndrome: toward a cost-effective management approach. Am J Manag Care 2001; 7: S26875.
  • 10
    Cash BD, Schoenfeld PS, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002; 97: 28129.
    Direct Link:
  • 11
    Bossuyt PM, Reitsma JB, Bruns DE, et al. Standards for reporting of diagnostic accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Br Med J 2003; 326: 414.
  • 12
    Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for reporting of diagnostic accuracy. Clin Chem 2003; 49: 16.
  • 13
    Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003; 49: 718.
  • 14
    Manning AP, Thompson WG, Heaton KW, et al. Towards a positive diagnosis of the irritable bowel syndrome. Br Med J 1978; 2: 6534.
  • 15
    Thompson WG, Dotewall G, Drossman DA, et al. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989; 2: 925.
  • 16
    Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45: II437.
  • 17
    Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastrenterol 1999; 94: 28037.
    Direct Link:
  • 18
    Saito YA, Locke GR, Talley NJ, et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 267981.
    Direct Link:
  • 19
    Thompson WG, Irvine EJ, Pare P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002; 47: 22535.
  • 20
    Mearin F, Badia X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending upon the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001; 36: 11212.
  • 21
    Brandt LJ, Locke R, Olden K, et al. An evidence based approach to the diagnosis of irritable bowel syndrome in North America. Am J Gastroenterol 2002; 97: S1S26.
  • 22
    Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 210831.
  • 23
    Schmulson MW, Chang L. Diagnostic approach to the patient with irritable bowel syndrome. Am J Med 1999; 107: 20S6S.
  • 24
    Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 65268.
  • 25
    Tolliver BA, Herrera JL, DiPalma JA. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 1994; 89: 1768.
  • 26
    Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: a case–control study in patients fulfilling the Rome II criteria referred to secondary care. Lancet 2001; 358: 15048.
  • 27
    Hamm LR, Sorrells SC, Harding JP, et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. Am J Gastroenterol 1999; 94: 127982.
    Direct Link:
  • 28
    Helfand M, Redfern CC. Screening for thyroid disease: an update. Ann Int Med 1998; 129: 14458.
  • 29
    Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 28692.
  • 30
    O'Leary C, Wieneke P, Buckley S, et al. Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol 2002; 97: 14637.
    Direct Link:
  • 31
    Scrimshaw NS, Murray EB. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr 1988; 48: 1079159.
  • 32
    Bourlioux P, Pochart P. Nutritional and health properties of yogurt. World Rev Nutr Diet 1988; 56: 21758.
  • 33
    Vesa TH, Seppo LM, Marteau PR, et al. Role of irritable bowel syndrome in subjective lactose intolerance. Am J Clin Nutr 1998; 67: 7105.
  • 34
    Tolliver BA, Jackson MS, Jackson KL, et al. Does lactose maldigestion really play a role in the irritable bowel syndrome? J Clin Gastroenterol 1996; 23: 157.
  • 35
    Bohmer CJ, Tuynman ARE. The effect of a lactose-restricted diet in patients with a positive lactose tolerance test, earlier diagnosed as irritable bowel syndrome: a 5-year follow-up study. Eur J Gastroenterol Hepatol 2001; 13: 9414.
  • 36
    Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 35036.
    Direct Link:
  • 37
    Pimental M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo controlled study. Am J Gastroenterol 2000; 95: 35036.
  • 38
    Francis CY, Duffy JN, Whorwell PJ, et al. Does routine ultrasound enhance diagnostic accuracy in irritable bowel syndrome? Am J Gastroenterol 1996; 91: 134850.
  • 39
    Lanng C, Mortensen D, Friis M, et al. Gastrointestinal dysfunction in a community sample of subjects with symptoms of irritable bowel syndrome. Digestion 2003; 67: 1419.
  • 40
    MacIntosh DG, Thompson WG, Patel DG, et al. Is rectal biopsy necessary in irritable bowel syndrome? Am J Gastroenterol 1992; 87: 14079.
  • 41
    Yawn BP, Lydick E, Locke GR, et al. Do published guidelines for evaluation of irritable bowel syndrome reflect practice? BMC Gastroenterol 2001; 1: 11.
  • 42
    Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician–patient interaction. Ann Intern Med 1995; 122: 10712.
  • 43
    Harvey RF, Mauad EC, Brown AM. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet 1987; I: 9635.
  • 44
    Fine KD, Seidel RH, Do K. The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc 2000; 51: 31826.
  • 45
    Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999; 116: 146486.